Catalent stock rockets 21% premarket on report of takeover interest from Danaher
Life Sciences Company Danaher Corp. (DHR) is interested in taking over contract manufacturer Catalent Inc. (CTLT) and is willing to pay a significant premium for the company, Bloomberg reported Monday, citing people familiar with the matter. It's unclear whether Catalent is receptive, the people said, adding that a deal is not imminent. Catalent declined to comment, while Danaher did not respond to Bloomberg's request for comment. The report sent Catalent stock up 21% in premarket trade. Catalent is based in Somerset, New Jersey, and provides delivery technologies for drugs, biologics and consumer health products, including producing vaccines for Moderna (MRNA) and Johnson & Johnson (JNJ). It has a market cap of just over $10 billion, according to FactSet.
(END) Dow Jones Newswires
February 06, 2023 06:35 ET (11:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.